GSK Settles Hundreds Of Avandia Suits Before FDA Advisory Cmte. Meeting

The upcoming FDA advisory committee meeting on Avandia (rosiglitazone) may be putting pressure on GlaxoSmithKline to settle a chunk of the product liability suits facing the company